Venlafaxine, amitriptyline use during pregnancy associated with increased risk for gestational diabetes

Have you ever heard the phrase “If I only had a dollar for every time….”? There is nowhere that this seems to be the comment more often than when the FDA adds a side effect and later there are enough challenges to get them to change it. My favorite one …

This study covers the implications of sleep and its effect on behavioral and physiological implications in teens with type 1 diabetes.

Did the FDA make a mistake by labeling SGLT2 inhibitors as a fracture risk?

In regards to pharmacotherapy, patients with type 1 diabetes end up solely relying on insulin therapy for their diabetes management: what if there is an add on option?

Risks increased for all-cause mortality, cardiovascular events, microvascular complications

Whenever you look at the slide from the international diabetes center that shows the progression to diabetes, there is always an arrow pointing to the decline in insulin production as resistance increases. Supposedly fixing this problem was the target of the first oral diabetes medication, chlorpropamide, which became available in …

After almost 50 years, is the age of sulfonylureas coming to an end?

The results of a recent phase III study may offer children with diabetes a new route for better glycemic control. 

The study findings explore the gastric bypass results of different age groups in hopes of learning more about the procedure and the potential risks and benefits that come with it.